arrow_back Civic Audit
Share share

Easier Return of Unused Medications: New Rules for Take-Back Programs

This act simplifies the return of unused medications, especially opioids, through take-back programs. It allows for safer disposal of unneeded substances, reducing the risk of misuse. Citizens can expect more efficient and potentially more incentivized drug return programs.
Key points
Entities collecting drugs can open packages to identify contents, enabling incentive programs for those returning medications.
These entities gain the option to securely transport collected drugs to another destruction site, instead of destroying them on-site.
The changes aim to enhance public safety by limiting access to unused controlled substances.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 117_HR_6896
Sponsor: Rep. Foxx, Virginia [R-NC-5]
Process start date: 2022-03-02
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

RETURN Act of 2022

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_6896.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-03-02.

What are the main provisions?

Key points include:

  • Entities collecting drugs can open packages to identify contents, enabling incentive programs for those returning medications.
  • These entities gain the option to securely transport collected drugs to another destruction site, instead of destroying them on-site.
  • The changes aim to enhance public safety by limiting access to unused controlled substances.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Foxx, Virginia [R-NC-5].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health Security